Glanbia (FRA:GL9) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:GL9 Glanbia PLC FRA:GL9
62 GF Score
Price €22.62
GF Value €12.50
Valuation Significantly Overvalued
! 5 Warning Signs
View Full Analysis

What is Glanbia Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

FRA:GL9
62GF Score
Glanbia PLC FRA:GL9
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Glanbia (FRA:GL9) Overvalued in 2026?

Based on GuruFocus' analysis, Glanbia stock appears to be overvalued. The current stock price of €22.62 is trading 81% above its estimated GF Value™ of €12.50. GuruFocus considers Glanbia to be Significantly Overvalued.

Key valuation signals for FRA:GL9:

  • Dividends Received:
  • GF Value™: €12.50 vs. price of €22.62 (81% above fair value)
  • GF Score™: 62/100 with 5 warning signs

No single metric tells the full story. See the FRA:GL9 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Glanbia Business Description

Address Ring Road, Glanbia House, Kilkenny, IRL, R95 E866
Glanbia PLC is a ingredient and branded performance nutrition manufacturer company. Company offer an incredible breadth of expertise in nutrition. It works with food and beverage companies and sell the products across the globe . The company segments include Performance Nutrition (PN), Health & Nutrition (H&N) and Dairy Nutrition (DN). The company generates majority of the revenue from Performance Nutrition segment. Geographically, it has majority revenue from North America followed by Europe and Asia.
62GF Score

Get the complete analysis for FRA:GL9

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€22.62
Price
€12.50
GF Value